Biotech

All Articles

Acepodia, Pfizer click all together for chemistry-based tissue therapy

.Phone it a case of excellent chemistry: Acepodia, a biotech based upon Nobel Champion science, is a...

Praxis epilepsy drug lessens seizures in period 2 trial

.Practice Accuracy Medicines has actually scored another midphase win in epilepsy this year, with it...

Three execs resign as Dyne messages blended information for DMD applicant

.After getting away from a scientific grip a number of years back, Dyne Rehab has actually revealed ...

Arrowhead fires off phase 3 information in unusual metabolic disease in advance of market clash with Ionis

.Arrowhead Pharmaceuticals has revealed its own give before a possible showdown with Ionis, posting ...

Pfizer, Valneva show lyme condition chance helpful for second enhancer

.Pfizer as well as Valneva may have about two additional years to wait before they help make the ini...

Fierce Biotech Managing Editor Ayla Ellison Speaks Patronize Michelle Benz on the Future of Biotech.

.Let's dive into a conversation along with Ayla Ellison, Tough Biotech Managing Editor and also Mich...

New information demonstrate how Bayer's asundexian failed to avoid movements

.Bayer put on hold the period 3 trial for its own aspect XIa inhibitor asundexian late in 2013 after...

Sanofi's tolebrutinib stops working 2 of 3 late-stage MS trials

.Sanofi is still set on taking its own several sclerosis (MS) med tolebrutinib to the FDA, executive...

Galapagos' stockpile as fund shows intent to shape its own progression

.Galapagos is coming under added pressure coming from real estate investors. Having actually created...

Cell- concentrated Sana scoops first CSO-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of significant leadership hirings, firings ...